Literature DB >> 5782719

Acute mountain sickness.

I Singh, P K Khanna, M C Srivastava, M Lal, S B Roy, C S Subramanyam.   

Abstract

Mesh:

Substances:

Year:  1969        PMID: 5782719     DOI: 10.1056/NEJM196901232800402

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  64 in total

Review 1.  Altitude illness.

Authors:  P W Barry; A J Pollard
Journal:  BMJ       Date:  2003-04-26

Review 2.  Acute mountain sickness. Effects and implications for exercise at intermediate altitudes.

Authors:  E C Pigman
Journal:  Sports Med       Date:  1991-08       Impact factor: 11.136

3.  Peak expiratory flow at altitude.

Authors:  P S Thomas; R M Harding; J S Milledge
Journal:  Thorax       Date:  1990-08       Impact factor: 9.139

4.  Effect of altitude on spirometric parameters and the performance of peak flow meters.

Authors:  A J Pollard; N P Mason; P W Barry; R C Pollard; D J Collier; R S Fraser; M R Miller; J S Milledge
Journal:  Thorax       Date:  1996-02       Impact factor: 9.139

5.  Subarachnoid hemorrhage at high altitude.

Authors:  J A Litch; B Basnyat; M Zimmerman
Journal:  West J Med       Date:  1997-09

6.  Possible peripheral neuropathy at high altitude.

Authors:  K Echizenya; K Tashiro
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-08       Impact factor: 10.154

7.  Acute high-altitude illness: a clinically orientated review.

Authors:  Tom Smedley; Michael Pw Grocott
Journal:  Br J Pain       Date:  2013-05

8.  High altitude medical problems.

Authors:  H N Hultgren
Journal:  West J Med       Date:  1979-07

9.  Shilajit: A panacea for high-altitude problems.

Authors:  Harsahay Meena; H K Pandey; M C Arya; Zakwan Ahmed
Journal:  Int J Ayurveda Res       Date:  2010-01

10.  Ophthalmodynamometry for ICP prediction and pilot test on Mt. Everest.

Authors:  Henry W Querfurth; Philip Lieberman; Steve Arms; Steve Mundell; Michael Bennett; Craig van Horne
Journal:  BMC Neurol       Date:  2010-11-01       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.